An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta) in Patients With Hunter Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07344376

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:37.539638+00:00

Published At

2026-01-15T00:00:00+00:00

Record Updated At

2026-01-15

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["MPS II", "Hunter Syndrome (MPS II)", "Hunter Syndrome", "Hunterase", "GC1111"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-01-15"

protocolSection.identificationModule.nctId

"NCT07344376"

protocolSection.identificationModule.officialTitle

"An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta) in Patients With Hunter Syndrome"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• MPS II (protocolSection.conditionsModule.conditions)
• Hunter Syndrome (MPS II) (protocolSection.conditionsModule.conditions)
• Hunter Syndrome (protocolSection.conditionsModule.conditions)
• Hunterase (protocolSection.conditionsModule.conditions)
• GC1111 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.